Learn More
Medchemexpress LLC Bozitinib | 1440964-89-5 | 98.9% | 424.38 | C20H15F3N8 | 50MG

Supplier: Medchemexpress LLC HY12501750MG
Bozitinib is a selective, ATP-competitive c-MET (HGFR) kinase inhibitor with reported blood-brain barrier permeability, supplied for preclinical research applications. It is provided with defined chemical characterization and high purity suitable for in vitro and in vivo studies.
- Selective c-MET kinase inhibition.
- Demonstrated blood-brain barrier permeability.
- Suitable for in vitro and in vivo preclinical research.
- High chemical purity (98.9%).
- Molecular formula C20H15F3N8; molecular weight 424.38 g/mol.
- Available in multiple pack sizes including 50 mg.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.